291 related articles for article (PubMed ID: 29098528)
1. Safety of fertility preservation in breast cancer patients in a register-based matched cohort study.
Rodriguez-Wallberg KA; Eloranta S; Krawiec K; Lissmats A; Bergh J; Liljegren A
Breast Cancer Res Treat; 2018 Feb; 167(3):761-769. PubMed ID: 29098528
[TBL] [Abstract][Full Text] [Related]
2. Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis.
Marklund A; Lekberg T; Hedayati E; Liljegren A; Bergh J; Lundberg FE; Rodriguez-Wallberg KA
JAMA Oncol; 2022 Oct; 8(10):1438-1446. PubMed ID: 36006625
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.
Kim J; Turan V; Oktay K
J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
[TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
5. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
7. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
[TBL] [Abstract][Full Text] [Related]
10. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
[TBL] [Abstract][Full Text] [Related]
11. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
12. Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer.
Muñoz E; Domingo J; De Castro G; Lorenzo I; García-Velasco JA; Bellver J; Pellicer A; Garrido N
Reprod Biomed Online; 2019 Nov; 39(5):860-867. PubMed ID: 31564650
[TBL] [Abstract][Full Text] [Related]
13. Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation.
Marklund A; Lundberg FE; Eloranta S; Hedayati E; Pettersson K; Rodriguez-Wallberg KA
JAMA Oncol; 2021 Jan; 7(1):86-91. PubMed ID: 33211089
[TBL] [Abstract][Full Text] [Related]
14. Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer.
Sonigo C; Amsellem N; Mayeur A; Laup L; Pistilli B; Delaloge S; Eustache F; Sifer C; Rakrouki S; Benoit A; Peigné M; Grynberg M
Fertil Steril; 2023 Mar; 119(3):465-473. PubMed ID: 36473609
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
[TBL] [Abstract][Full Text] [Related]
16. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
Azim AA; Costantini-Ferrando M; Oktay K
J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
[TBL] [Abstract][Full Text] [Related]
17. Fertility preservation in women with borderline ovarian tumours.
Mangili G; Somigliana E; Giorgione V; Martinelli F; Filippi F; Petrella MC; Candiani M; Peccatori F
Cancer Treat Rev; 2016 Sep; 49():13-24. PubMed ID: 27428850
[TBL] [Abstract][Full Text] [Related]
18. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
[TBL] [Abstract][Full Text] [Related]
19. Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review.
Cruz MR; Prestes JC; Gimenes DL; Fanelli MF
Fertil Steril; 2010 Jun; 94(1):138-43. PubMed ID: 19339000
[TBL] [Abstract][Full Text] [Related]
20. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM; Ramanathan P
Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
